Cipla

Cipla promoter loses SEZ land

Posted by : 9975797577
Price when posted : BSE: Rs 234.75 ( -1.39 % ), NSE: Rs. 234.30 ( -1.43 % )

View full thread (1 messages)

Tracked by: 0 Boarder

Goa government scraps three notified SEZs, plans to
take back land from the promoters--Cipla, K. Raheja, and Peninsula Land
...

NSE Announcements on Cipla

Posted by : MMB Messenger
Price when posted : [Cipla - BSE:Rs. 235.00 NSE:Rs. 234.55 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Cipla Ltd. has informed the Exchange that at the Annual General Meeting of the Company held on August 28, 2008, all resolutions were passed unanimously. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...

BSE Announcements on Cipla

Posted by : MMB Messenger
Price when posted : [Cipla - BSE:Rs. 240.20 NSE:Rs. 240.05 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Cipla Ltd has informed BSE that that the Annual General Meeting (AGM) of the Company was held on August 28, 2008....

good growth

Posted by : basit222
Price when posted : BSE: Rs 237.25 ( 0.25 % ), NSE: Rs. 237.40 ( 0.36 % )

View full thread (1 messages)

Tracked by: 0 Boarder

Cipla Limited is a pharmaceutical company based in India. During the fiscal year ended March 31, 2007 (fiscal 2007), the Company launched many drugs and formulations, which include Ciclohale, which is a steroid inhaler for asthma prophylaxis; SimplyOne, which is a combination therapy for asthma prophylaxis; Neosurf, which is a rescue treatment for neonatal respiratory distress syndrome, and Elcepan, which is a combination therapy for epilepsy. The Company has alliances with nine generic majors including Teva Pharmaceuticals USA, Inc., Watson Pharmaceuticals, Inc., Eon Labs, Inc. and Akorn, Inc. for over 125 projects. It has entered into a research agreement with Avestha Gengraine Technologies Private Limited, to work on a collaborative biopharmaceuticals development programme. The Company has set up a wholly owned subsidiary Cipla FZE, in October 2006, at Jebel Ali Free Zone, Dubai, U.A.E. Cipla has reported a 16.9% rise in net profit to Rs 140.04 crore in Q1 June 2008 over Q1 June 2007. The company�s net sales rose 33.9% to Rs 1207.12 crore in Q1 June 2008 over Q1 June 2007. Driven by a smart 50 per cent growth in exports, the Rs 4,227 crore Cipla posted a top line growth of nearly 34 per cent in the June 2008 quarter. The relatively low base of Q1FY08 and a weaker rupee notwithstanding, this is the fourth quarter of successive good growth recorded by the drug major. Revenues from the home market in June too have grown at a reasonably good 16 per cent and consequently the operating profit margin expanded 360 basis to 22 per cent, after adjusting for a forex loss of Rs 75 crore. The forex loss, however, depressed the net profit which rose just 17 per cent to Rs 140 crore.We advise you to maintain HOLD on the stock with a long term view ...

Cipla looks excellent

Posted by : Guest
Price when posted : BSE: Rs 237.25 ( 0.25 % ), NSE: Rs. 237.40 ( 0.36 % )

View full thread (2 messages)

Tracked by: 1 Boarder

once cipla touches 220, ashwani gujral will revise his estimates to 180. it is part of the game....played day in and out....

In reply to:

Cipla looks excellent

Posted by : basit222

Technical Analyst, Ashwani Gujral is of the view that Cipla looks excellent to go upto Rs 270-275

Cipla looks excellent

Posted by : basit222
Price when posted : BSE: Rs 235.60 ( -1.85 % ), NSE: Rs. 236.70 ( -1.66 % )

View full thread (2 messages)

Tracked by: 1 Boarder

Technical Analyst, Ashwani Gujral is of the view that Cipla looks excellent to go upto Rs 270-275...

Cipla behaves inversly to the sensex

Posted by : Guest
Price when posted : BSE: Rs 237.85 ( -0.92 % ), NSE: Rs. 237.60 ( -1.29 % )

View full thread (2 messages)

Tracked by: 0 Boarder

It doesn\\`t mean anything. Treat the company like a business and understand it. Invest in it at the right price for value obtained....

In reply to:

Cipla behaves inversly to the sensex

Posted by : prasadrn

Hi, I have noticed a fact that Cipla\\\'s behavious is inversly proportional to the sensex. Can anyone explain the rationale of this behavior.

target 275

Posted by : basit222
Price when posted : BSE: Rs 239.00 ( -0.44 % ), NSE: Rs. 239.65 ( -0.44 % )

View full thread (1 messages)

Tracked by: 0 Boarder

buy cipla for short term target 275/...

buy back

Posted by : SouRatta
Price when posted : BSE: Rs 234.00 ( -0.45 % ), NSE: Rs. 234.65 ( 0.13 % )

View full thread (2 messages)

Tracked by: 0 Boarder

there is no buy back. ignore this rumour...

In reply to:

buy back

Posted by : basit222

any news for buy back

buy back

Posted by : basit222
Price when posted : BSE: Rs 233.45 ( 0.56 % ), NSE: Rs. 234.05 ( 0.95 % )

View full thread (2 messages)

Tracked by: 0 Boarder

any news for buy back...

CIPLA

Posted by : SouRatta
Price when posted : BSE: Rs 236.05 ( 1.68 % ), NSE: Rs. 236.35 ( 1.94 % )

View full thread (1 messages)

Tracked by: 0 Boarder

If ur not in urgent need of money, i would suggest you to wait for atleast another 3 months. I am sure it will cross you buy prices. don't sell in loss. ...

In reply to:

CIPLA

Posted by : meet1234

I HAVE 100 SHARES CIPLA FOR THE RATE OF255 SHALL I HOLD OR SELL

Will Cipla Reach To 240 Levels?

Posted by : JuggyD
Price when posted : BSE: Rs 235.65 ( 1.51 % ), NSE: Rs. 236.30 ( 1.92 % )

View full thread (1 messages)

Tracked by: 0 Boarder

Will Cipla Reach To 240 Levels in Near Future say 4-5 days?...

NSE Announcements on Cipla

Posted by : MMB Messenger
Price when posted : [Cipla - BSE:Rs. 232.15 NSE:Rs. 231.85 when posted]

View full thread (1 messages)

Tracked by: 0 Boarder

Cipla Ltd. has informed the Exchange that dividend warrants for the year 2007-2008 will be dated on or about September 04, 2008 and will be dispatched to the shareholders within the stipulated time limit....

Cipla behaves inversly to the sensex

Posted by : prasadrn
Price when posted : BSE: Rs 231.85 ( 3.02 % ), NSE: Rs. 231.05 ( 2.53 % )

View full thread (2 messages)

Tracked by: 0 Boarder

Hi, I have noticed a fact that Cipla\\\'s behavious is inversly proportional to the sensex. Can anyone explain the rationale of this behavior....

Clinton Foundation buys AIDS drug from CIPLA

Posted by : zoombusiness
Price when posted : BSE: Rs 225.05 ( -3.70 % ), NSE: Rs. 225.35 ( -3.61 % )

View full thread (1 messages)

Tracked by: 0 Boarder

The Bill Clinton Foundation has bought huge quantities of paediatric antiretroviral formulations from Mumbai-based Cipla for distribution in 62 developing countries in Africa, Asia, Latin America and the Caribbean.

Together, these countries represent more than 90% of children living with HIV/AIDS in developing countries. Some 4.3 million children under 15 have died worldwide as a result of AIDS.

Last year, over six lakh children were newly-infected with HIV, and more than 1,600 are infected every day, according to recent estimates. Confirming the development, Amar Lulla, Cipla\'s joint MD, said, \"Since we are the only firm to have developed a paediatric dosage form of the AIDS drug, the Clinton Foundation has taken advantage of the generic version and included it in its distribution network.\"

Children are an afterthought when it comes to producing appropriate formulations of medicines. Of the 22 anti retrovirals approved by the US Food and Drug Administration till last year, eight are not approved for use in children and nine are not available in paediatric formulation.

Cipla\'s child-friendly drug is a three-in-one tablet that replaces individual solutions, for less than $60 per year, or 16 cents per day, per child. Given that many current AIDS drugs are made only in dosages and formats appropriate for adults, the new generic drug has been made specifically for easy administration to children.

The drug needs no refrigeration, which is an advantage in underdeveloped countries lacking electricity, and can
be split in half and dissolved fully in water, making it suitable for use even in children too young to swallow pills. The dosing depends on the child\'s weight.

-TOI-...